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Abstract 
Background: Matrix metalloproteinases (MMPs) are important enzymes in the tumor 
microenvironment associated with progression of cervical intraepithelial neoplasia 
(CIN) towards squamous cell carcinoma (SCC) of the cervix. However, the role of 
MMPs in the inflammatory process associated with Chlamydia trachomatis infection 
concomitant with the carcinogenic process driven by HPV has not yet been addressed. 
In the present study we analyzed the estate of the MMP-9/RECK axis in cervical 
carcinogenesis. Methods: The levels of MMP-9 and RECK expression were analyzed 
by immunocytochemistry in liquid-based cytology samples from 136 women with high-
grade cervical lesions (CIN2/CIN3) and cervical SCC diagnosed by LLETZ, and in 196 
women without cervical neoplasia or CIN1. Real-Time qPCR was performed to analyze 
expression of MMP-9 and RECK in fifteen cervical samples. The presence of HPV-
DNA and other genital pathogens was evaluated by PCR. Results: We found a higher 
expression of MMP-9 (OR=4.2; 95%CI: 2.2-7.8) and lower expression of RECK 
(OR=0.4; 95%CI: 0.2-0.7) in women with CIN2/CIN3/SCC when compared to women 
from the control group (no neoplasia/CIN1). It was also found a statistically significant 
association between MMP-9/RECK imbalance and infection by alpha-9 HPV and C. 
trachomatis. The prevalence of Chlamydia trachomatis infection was significantly 
higher in women with high-grade cervical disease (OR= 3.7; 95%CI: 1.3-11.3). 
Conclusions: MMP-9/RECK imbalance in cervical smears is significantly associated 
with high-grade cervical diseases and infection by alpha-9 HPV and Chlamydia 
trachomatis. Impact: MMP-9/RECK imbalance during cervical inflammation induced 
by Chlamydia trachomatis might play a role in HPV-mediated cervical carcinogenesis.  
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Introduction 
 Cervical cancer is etiologically associated with infection with high-oncogenic 
risk human papillomavirus (HPV) (1). This tumor has the capacity to metastasize to 
distant tissues and organs, a fact strongly associated with failure of cervical cancer 
treatment. The evolution of metastasis is a multistep process and its initial stages can be 
identified in the pre-neoplasic phase (2). Transformation of a noninvasive cervical 
neoplasia into an invasive cervical carcinoma requires the migration of epithelial cells 
through the subjacent extracellular matrix, a process in which the matrix 
metalloproteinases (MMPs) play a critical role by degrading extracellular matrix 
components (3,4). 
MMPs are zinc-dependent endopeptidases involved in various physiological and 
pathological processes including tissue remodeling, development and regulation of 
inflammation (5,6). During carcinogenesis, these enzymes promote changes in the 
stroma and microenvironment contributing to tumor progression (5-7). Furthermore, 
MMPs are also dependent on local equilibrium with its physiological inhibitors, such as 
the RECK protein (Reversion-inducing Cysteine-rich protein with Kazal motifs), which 
regulates MMP-2 and MMP-9 activities (4,7). 
Overexpression of MMP-2 and MMP-9 has been shown to occur in invasive 
cervical carcinoma and high-grade cervical lesions(3,8,9).We have previously shown 
that HPV16-positive cell lines express higher levels of MMP-2, MT1-MMP and TIMP-
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2 than HPV-negative cell lines.  MMP-9 was expressed at very low levels in both HPV-
negative and HPV-positive cell lines (10). In order to analyze MMPs status in a system 
that reproduces in vivo conditions, we have previously developed organotypic epithelial 
cultures with keratinocytes expressing HPV 16 oncoproteins. We have demonstrated 
that HPV 16 E7 induces pro-MMP-9 activity, and that E6 and E7 coexpression down-
regulates RECK protein levels (11). This latter study also demonstrated that, even in 
small number of clinical samples, there is an inverse correlation between RECK 
expression and degree of cervical lesion. Furthermore, previous work from our group 
demonstrated the association between high-grade cervical lesions and high expression 
of MMP-9 in conventional Pap-smears, especially when the patient had concomitant 
genital infection (12).  
          Clinical studies have shown an association between high-grade cervical 
intraepithelial neoplasia and Chlamydia trachomatis infection (13-16). Considering that 
concomitant genital infections have been assumed to be risk factors for HPV persistence 
(14), we hypothesized that infection-induced cervical inflammation were capable of 
influencing the carcinogenic process driven by HPV. One can consider the role of 
MMPs in inflammatory process, since the involvement of these enzymes has already 
been demonstrated in organotypic cultures of fallopian tube infected in vitro by C. 
trachomatis (17) and in the pathology of ocular trachoma (18). However, within the 
context of cervical carcinogenesis, this possible relationship has not yet been elucidated. 
It is biological plausible that chronic infection by C. trachomatis causes an unresolved 
cervical inflammation that may lead to tissue damage, involving an interplay between 
HPV, MMPs and their inhibitors. Therefore, in the present study we evaluated the role 
of MMP-9 and RECK expression in cervical lesions and genital infections. 
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Materials and Methods 
Subject’s inclusion and sample collection   
This cross-sectional study included 332 women attending the CAISM Women’s 
Hospital (Centro de Atenção Integral à Saúde da Mulher), Family Planning of Human 
Reproduction Unit, in the School of Medical Sciences, State University of Campinas  
(UNICAMP), from August 2013 to August 2014. The case group was composed of 136 
women that underwent large loop excision of the transformation zone (LLETZ) due to 
high grade cytological abnormalities in referral Pap-smears. This group had a confirmed 
histological diagnosis of Cervical Intraepithelial Neoplasia grade 2 (CIN2; n=31), 
Cervical Intraepithelial Neoplasia grade 3 (CIN3; n=80) or Squamous Cell Carcinoma 
(SCC; n=25). The control group was composed of 196 women who presented at least 
two previous normal Pap-smears (n=162), cervicitis (n=9) or Cervical Intraepithelial 
Neoplasia grade 1 (CIN1; n=25) diagnosed by LLETZ.  No cases of adenocarcinoma 
were included. CIN1 cases were included in the control group since low-grade cervical 
lesions have more similar characteristics to those of a HPV productive benign infection 
than of a transforming infection (19). Morphological diagnosis of biopsies obtained by 
LLETZ were assessed according to the International Histological Classification of 
Tumours (World Health Organization) (20). 
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This study was approved by the Ethics in Research Committee of the School of 
Pharmaceutical Sciences of the University of São Paulo (USP) (ref. 411.692/2013). 
After signing the informed consent form, women were submitted to a specular 
examination for the collection of cervical samples, which were preserved partly in 
Surepath® vials (BD SurepathTM, Pap test) for liquid-based cytology (LBC), RNA and 
DNA extraction, and partly in sterile saline medium for cervical infections diagnosis. 
We also collected a cervical smear to perform a GRAM-stained bacterioscopy.  
An eight-milliliter fraction of the cervical sample collected in the Surepath® vial 
was centrifuged twice with the addition of 4 mL of gradient wash buffer. The resulting 
cellular pellet was suspended in 2 mL of Surepath® medium. From this cellular 
suspension, 200 µL were used in order to prepare the LBC slides, 200 µL were used for 
DNA extraction (for HPV genotyping) and 200 µL for RNA extraction (for analysis of 
gene expression). 
Immunocytochemistry for MMP-9 and RECK evaluation in LBC slides  
Liquid based cytology (LBC) slides were used to determine the expression of 
MMP-9 and RECK by immunocytochemistry analysis. In order to prepare the LBC 
slides, we used the automated PrepStain® system (TriPath Imaging, Inc., Burlington, 
NC). As a positive control of MMP-9 labelling, we used the HT1080 cell line derived 
from human fibrossarcoma (American Type Culture Collection, Manassas, VA, USA), 
which was chosen because it is known to be abundant in MMP-9. As a positive control 
for RECK labelling, we used primary human fibroblasts extracted from human foreskin 
at the Clinical Cytopathology Laboratory of the School of Pharmaceutical Sciences - 
USP. 
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To evaluate the expression of MMP-9, the primary antibody anti-MMP-9 (MAB 
13415, Chemicon-Millipore; Temecula, CA, USA) was used at a 1:150 dilution in 
phosphate buffer saline solution (PBS). To evaluate RECK expression we used the 
primary antibody anti-RECK (BD 611512, Biosciences, San Jose, CA, USA) also at the 
1:150 dilution in PBS. Incubation with primary antibodies was performed overnight in a 
wet chamber at 4°C. Incubation with secondary antibody and staining with DAB 
chromogen was performed using the Envision + Systems/HRPP commercial kit 
(K4007/DAKO Cytomation, CA, USA). After the immunocytochemical reaction, we 
proceeded to nuclei staining with hematoxylin. Immunocytochemical analysis was 
performed on 321 LBC slides for MMP-9 protein and on 327 LBC slides for RECK 
protein.  
Criteria for analyzing immunocytochemistry for MMP-9 and RECK in LBC slides 
In order to analyze the immunocytochemistry slides, we adapted the criteria 
described by Li et al. (9). We performed a blind test in which the observer was not 
informed of the diagnosis of any cervical lesions. The slides were analyzed at 400x 
magnification using a light microscope. Cells were counted and classified as "positive" 
or "negative" according to DAB chromogen staining: brown stained cells were 
considered as "positive" regardless of the intensity of the color (pale-yellow, brown or 
yellow-brown), and blue stained cells (hematoxylin only) were considered "negative". 
Counting was performed in two distant random fields, avoiding the specimen edges. In 
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case of discrepant scores between these two fields, a third field was counted. Slides 
grading was performed as follows: score 1 - 0 to 25% of DAB stained squamous cells; 
score 2 - 26 to 50% of DAB stained squamous cells; score 3 - 51 to 75% of DAB 
stained squamous cells; score 4 - more than 75% of DAB stained squamous cells. Both 
atypical and typical squamous cells were considered in the counting.  
At first, the analysis was performed by two independent observers (PCP and 
MGD) and, in case of disagreement, a third observer (MZ) was consulted. Scores 1 and 
2 were considered as negative or mild expression, and scores 3 and 4 were considered as 
moderate or accentuated expression. 
Real-time quantitative PCR (RT-qPCR) technique for evaluation of MMP-9 and 
RECK expression in cervical samples  
Total RNA was extracted from cervical samples of four women from the control 
group (no neoplasia/CIN1) and from eleven women in the case group (CIN2/ CIN3/ 
SCC) using Trizol® reagent (Invitrogen, Carlsbad, CA, USA). RNA samples were 
quantified by UV light spectrophotometer at 260 nm (ND-1000–NanoDrop- 
Wilmington, DE, USA) and RNA quality was verified by the A260/A280 ratio. cDNA was 
synthesized from 1µg RNA using the Reverse Transcription c-DNA High-capacity® kit 
(4388813, AB- Applied Biosystems, Warrington, UK). RT-qPCR was carried out using 
Taqman® specific primers for the genes of interest (MMP-9: Hs00234579-m1, RECK: 
Hs01019179-m1, Applied Biosystems, Warrington, UK). The assay was performed 
using ABI Prism® 7500 Sequence Detection System equipment (Applied Biosystems, 
New Jersey, USA), under the following conditions: activation of the AmpErase®UNG 
enzyme at 50°C for 2 minutes, followed by initial denaturation at 95°C for 10 minutes, 
40 cycles of 15 seconds at 95°C to end the denaturation process, and finally, annealing 
and extension of the primers and probe at 60°C for 1 minute. The level of gene 
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expression was calculated in relation to the endogenous controls expression (β-actin: 
Hs01060665-g1 and GAPDH: Hs02758991-g1, Applied Biosystems, New Jersey, USA) 
using the cycle threshold (Ct) method. 
 
 
HPV Genotyping 
DNA was extracted from 320 cervicovaginal samples collected in Surepath® 
vial. The cellular suspension was centrifuged and resuspended in 200µL of digestion 
solution (50mM Tris-HCL, 1mM EDTA, and 0.5% Triton X-100) + 200 µL TEP buffer 
(200µg/mL of proteinase K in TE). After 24 hours of digestion at 550C, the nucleic 
acids were purified with Phenol:Chloroform:Isoamyl Alcohol (25:24:1) followed by 
precipitation with 3M sodium acetate plus 2.5 volumes of absolute ethanol, and washing 
with 70% ethanol. The DNA pellet was re-suspended in 50µL of water. 
For HPV genotyping, we used the Linear Array Genotyping HPV 
kit (Roche Molecular Systems Inc., Pleasanton, CA, USA) according to the 
manufacturer’s protocol. This test uses target-DNA amplification by PCR and nucleic 
acids hybridization, detecting 37 types of low and high risk HPVs: HPV 6, 11, 16, 18, 
26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 
70, 71, 72, 73, 81, 82, 83, 84, IS39, and CP6108. Twelve women were excluded from 
HPV genotyping because of inadequate internal controls (β-globin).  
Multiplex PCR for seven genital infections  
Multiplex PCR (M-PCR) was performed for the diagnosis of seven concomitant 
genital infections in cervical samples in accordance with a previously standardized and 
validated method (21). The diagnosed concomitant genital infections were: Chlamydia 
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trachomatis, Herpes virus simplex 1 and 2 (HSV1 and HSV2), Neisseria gonorrhoeae, 
Mycoplasma hominis, Trichomonas vaginalis and Treponema pallidum. This analysis 
was performed at the Clinical Cytology Laboratory of the State University of Maringá 
(Laboratório de Citologia Clínica da Universidade Estadual de Maringá, UEM, 
Paraná, Brazil), using endocervical samples collected in sterile saline solution. DNA 
extraction of these samples was performed using the PureLink® RNA-DNA viral 
purification mini kit (12280-150, Invitrogen, Carlsbad, CA, USA) following 
manufacturer’s instructions.  Briefly, primers were characterized by compatible melting 
temperatures and yielded amplicons with sizes easily separable by polyacrilamyde gel 
electrophoresis. The protocol consisted of a reaction mixture of 25 µL containing 2.5 
mM of each dNTP, 0.6 mM of MgCl2, 25 mM of the specific primer, 5 µL of extracted 
DNA (50 ng of total sample) and 1 U of Platinum Taq DNA polymerase (Invitrogen, 
Carlsbad, CA, USA). The PCR conditions comprised of 35 amplification cycles of 
denaturation for 10 minutes at 94°C, annealing for 1 minute at 62°C, extension for 1 
minute at 72°C and final extension for 10 minutes at 72°C (Thermal cycler, Biosystem, 
CA, USA). The M-PCR products were analyzed in 8% polyacrylamide gels (Figure 1). 
Positive controls for all genital infections were derived from positive clinical samples 
diagnosed by reference methods, including culture and/or single PCR (sPCR) (22). 
Human β-globin-specific primers GH20/PC04 were used as internal controls for 
amplification and DNA integrity. The diagnosis of infections by multiplex PCR was not 
determined in 47 samples because of inadequate DNA internal control (β -globin). 
GRAM stained bacterioscopy 
The GRAM-stained slides were analyzed using the criteria described by Nugent 
et al. (23), which applies a scoring system for the presence of bacterial morphotypes of 
Gardnerella vaginalis, Lactobacillus sp and Mobiluncus sp. A score of 0-3 consisted of 
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normal microbiota, a score of 4-6 consisted of moderately disturbed microbiota, and a 
score equal or greater than 7 consisted of bacterial vaginosis (BV). 
Statistical analysis  
 The association between cervical lesions, genital infections, MMP-9 and 
RECK expression was evaluated by odds ratio (OR) with a 95% confidence interval 
(CI). The social and demographic characteristics were evaluated by Chi-square test. 
Multiple logistic regression analysis was used to calculate the odds ratios adjusted for 
the control variables, such as age, age at first sexual intercourse, ethnicity, parity, 
smoking and genital infections. The statistical analyzes described above were performed 
using the software SAS version 9.1.3 (SAS Institute, Cary, NC, EUA). The RT-qPCR 
gene expression of MMP-9 and RECK data was evaluated by Student’s T test, using 
GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, EUA). Significance 
level was defined at 5% for all statistical analysis. 
 
Results 
In the present study, the mean age of women was 35.4 + 10 years in the case 
group (CIN2/CIN3/SCC) and 35.8 + 8 years in the control group (no neoplasia/CIN1), 
with no statistical difference between the two groups. The profile of social and 
demographic characteristics in the study groups is shown in Table 1. We found a 
statistically significant higher frequency of smoking women in the case group when 
compared to the women in the control group (37% vs. 21%, respectively; p=0.001). We 
also found a higher frequency of women having had first sexual intercourse at age 
below 15 years in the study group (44%) when compared to the women in the control 
group (30%), and this difference was statistically significant (p=0.008). 
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We were able to gather data on a large spectrum of diagnosed genital infections 
from 300 women, by GRAM and M-PCR techniques. The most prevalent genital 
infection was BV (23%), followed by C. trachomatis (11%), Trichomonas vaginalis 
(3%) and Candida spp (3%). Neisseria gonorrhoeae was detected in four women 
(1.3%), while HSV1, HSV2 and Treponema pallidum were identified in two women 
each (0.9%). One case of Treponema pallidum was associated with an infection by C. 
trachomatis.  
The overall frequency of HPV was 52% (166/320). Of the 166 positive cases, 32% 
presented multiple HPV infections and 68% presented a single infection. We detected 
32 different types of HPV. The most prevalent type detected was HPV16 (34%), 
followed by HPV31 (8%), HPV52 (7%), HPV33 (6.5%), HPV58 (6%), HPV35 (5.5%), 
and HPV62 (4%). HPV18 represented 2.6% of the cases. In the case group 
(CIN2/CIN3/SCC), the frequency of HPV was 89%, while in the control group (no 
neoplasia/CIN1) the frequency was 24%. Regarding the oncogenesis risk of HPV, 91% 
of the HPV-positive cases were high-oncogenic risk types, 7% were low-oncogenic risk 
types and 2% were probably oncogenic.   
With regard to the phylogenetic distribution of HPV, infection by alpha-9 
species (which includes HPV types 16, 31, 33, 35, 52, 58) occurred in 75% of the cases, 
and infection by alpha-7 species (HPVs 18, 39, 45, 56, 59, 66, 68) occurred in 9% of the 
cases, while a combination of these two species was found in 5% of all cases. Other 
HPV species were inexpressively detected such as alpha-5, alpha-6, alpha-11 and alpha-
15. 
 The relationship of the HPV status with the MMP-9 and RECK expression is 
shown in Table 2, while the relationship between HPV and other infectious agents is 
represented in Table 3. We demonstrated that the presence of HPV, especially HPV16 
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and other alpha-9 HPV types, was significantly associated with increased expression of 
MMP-9 and low expression of RECK (Table 2). Women infected by C. trachomatis 
were more likely to have a moderate/accentuated MMP-9 expression, which was about 
2.6 times higher than the cases negative for C. trachomatis, with statistically significant 
results even after adjusting for the presence of HPV (OR= 2.6; 95%CI: 1.1-6.7). 
Furthermore, women with C. trachomatis had a higher prevalence of HPV multiple 
infection (OR= 2.7; 95%CI: 0.8-9.0). We also found a statistically significant 
association between C. trachomatis and high-grade cervical disease (CIN2/CIN3/SCC) 
when compared to the control group, i.e. no neoplasia/CIN1 cases (OR=3.7; 95%CI: 
1.1-4.9). However, this association was not seen for BV or other genital infections in 
general (Table 3) 
When we considered only women infected by high-risk HPV, we found that 
frequency of moderate/accentuated MMP-9 expression in women with concomitant 
infection by C. trachomatis was higher (17%) when compared to negative-mild MMP-9 
expression (6%), although this result was not statistically significant (OR=3.3; CI 95%: 
0.7-15.8). Moreover, frequency of moderate/accentuated RECK expression in C. 
trachomatis positive samples is lower (7%) when compared to negative-mild RECK 
expression (16%), but this difference was also not significant (OR= 0.4; CI 95%:  0.7-
1.7) (data not shown). 
 One important finding reported in Table 4 is that women from the case group 
(CIN2/CIN3/SCC) had a greater frequency of moderate/accentuated expression of 
MMP-9 than the women in the control group (no neoplasia/CIN1) and this association 
was statistically significant (OR= 4.2; 95%CI: 2.2-7.8). Additionally, when evaluating 
the expression of MMP-9 for each type of neoplasic cervical lesion in comparison with 
women without cervical neoplasia, we observed an increase in risk of 
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moderate/accentuated expression in higher grades of CIN. Table 4 also shows that there 
is a strong association between CIN3 and moderate/accentuated expression of MMP-9 
(OR=5.4, 95% CI 2.4-12.4). When considering RECK expression this relation is 
inverted: lower RECK expression is associated with higher grades of CIN. These results 
were also statistically significant after a multivariate analysis adjusted for the study 
variables, such as age, age at first sexual intercourse, ethnicity, parity, smoking and 
genital infections.  
Figure 2 represents the immunocytochemical staining for MMP-9 and RECK 
proteins, showing that there is a clear increase in the intensity and number of cells 
stained for MMP-9 in CIN3 lesions (Figure 2B) when compared to normal cervical 
smears (Figure 2A). Moreover, we observed a decrease in the expression of RECK in 
CIN3 lesions (Figure 2E) when compared to normal cervical smears (Figure 2D). 
Figures 2C and 2F show a graphic representation of the MMP-9 and RECK 
mRNA expression evaluated by RT-qPCR. We observed that, women in the case group 
(CIN2/CIN3/SCC) presented a higher MMP-9 mRNA expression than women in the 
control group (no neoplasia/CIN1), but this result was not statistically significant 
(p=0.2). On the other hand, there was a statistically significant lower RECK mRNA 
expression in the case group when compared to the control group (p=0.03). These 
results are consistent with the ones we found in the immunocytochemical analyzes.  
Discussion 
In this study, we presented MMP-9 and RECK expression analysis in LBC 
cervical samples of women with cervical intraepithelial neoplasia and cervical 
squamous cell carcinoma, concomitant with other genital infections. We found that 
higher expression of MMP-9 and lower expression of RECK is strongly associated with 
high-grade cervical lesions and with the presence of alpha-9 HPVs, which includes 
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HPV 16. Additionally, we demonstrated, for the first time to the best of our knowledge, 
that C. trachomatis infection is associated with MMP-9/RECK imbalance. This may 
constitute a possible mechanism by which inflammation contributes to HPV-mediated 
carcinogenesis. Furthermore, our results are in accordance with data from the literature 
that has already described the relation between C. trachomatis infection and high-grade 
cervical lesions (13-16). 
In a previous study from our group, da Silva Cardeal et al. (10) discussed that 
there is no correlation between RECK expression and low MMP activity in HPV16-
positive (SiHa, CAsKi) and HPV16-negative (C33A) human cervical carcinoma cell 
lines. In that model, the authors hypothesized that TIMP-2, but not RECK, is involved 
in MMP inhibition. However, in the present study, data from clinical samples evidenced 
an imbalance between MMP and RECK which has already been shown in other human 
cancers (24-26) and in organotypic epithelial cultures with HPV-infected keratinocytes 
(11). 
Our clinical data is in agreement with the study from Wang et al. (27), which 
demonstrated that higher expression of RECK and lower expression of MMP-9 and 
MMP-2 constitutes a positive prognostic survival factor in patients with invasive 
cervical carcinoma. Gosh et al. (28) investigated the gelatinolytic activity of matrix 
MMP-2 and MMP-9 in preinvasive and invasive carcinoma of the uterine cervix and 
concluded that both MMP-2 and MMP-9 have a role in cancer progression and 
remodeling of the ectocervix. Furthermore, a study conducted in cervical biopsies 
showed a decrease in RECK expression in preneoplasic and neoplasic lesions (11). 
Results from the present study show  that women infected by alpha-9 HPVs, 
which includes HPV16, are more likely to have higher expression of MMP-9 and lower 
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expression of RECK when compared to women infected by alpha-7 HPV or other HPV 
species. In this context, Cardeal et al. (11) indicated that HPV16  E7 expression is 
associated with increased pro-MMP-9 activity in the epithelial component of 
organotypic cultures, while E6 and E7 HPV16 oncoproteins co-expression down-
regulates RECK and TIMP-2 levels in organotypic cultures. Moreover, clinical studies 
have demonstrated that women infected by alpha-9 HPV have higher risk of CIN3 
development or CIN2 clinical progression, when compared to women infected by alpha-
7 HPV (29,30). 
Altogether, we can conclude that the analysis of MMP-9 expression in women 
infected by HPV could be an important tool to be used in clinical practice. Herein, we 
simultaneously investigated MMP-9, RECK and HPV in liquid-based cytology samples, 
which is a simple screening method that allows morphological and molecular analyzes 
in the same sample. Not all women infected by HPV will present a clinically important 
lesion or will develop cervical carcinoma (19), therefore it is necessary to search for 
new biomarkers that could positively impact the efficacy and screening outcome of the 
Pap-test.  
It is also important to consider other factors that might interfere in the regulation 
of such biomarkers; therefore, in this study, we analyzed the effect of concomitant 
genital infections on the protein expression of MMP-9 and RECK. The presence of 
genital infection is increasingly considered as a risk factor for the persistence of HPV 
infection and progression of the associated lesions, and the mechanisms of these 
associations have been the object of various studies (31-34).  In conventional Pap-
smears, Matheus et al. (12) showed a high expression of MMP-9 in the presence of 
genital infections. Herein, we found a significant association between C. trachomatis 
and high-grade cervical lesions (CIN2/CIN3/SCC) (OR: 3.7; 95%:1.3-11.3), which has 
on August 19, 2015. © 2015 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on August 10, 2015; DOI: 10.1158/1055-9965.EPI-15-0420 
18 
 
already been amply demonstrated in the literature (13-16). Additionally, we found that 
women with C. trachomatis have a 2.7 higher chance of presenting multiple infections 
than a single infection by HPV, although this result was not statistically significant in 
this sample size (OR=2.7, 95% CI: 0.8-9.0). Similarly, Paba et al. (32) demonstrated 
that the risk of a woman presenting an infection due to two concomitant types of HPV is 
7.2 times higher in the presence of C. trachomatis. One large longitudinal study also 
showed that prior infection by C. trachomatis is the greatest risk factor for the 
persistence of HPV DNA (33).  Furthermore, Jensel et al. (16) concluded that repeated 
infections by C. trachomatis increase the risk of CIN3 development among women with 
prevalent and persistent high-risk HPV infection. 
The possible causal factors of the association between C. trachomatis, HPV and 
cervical neoplasia are poorly understood. The inflammatory response, cellular 
hypertrophy and squamous metaplasia caused by C. trachomatis infection are thought 
as possible mechanisms of the association between C. trachomatis and cervical 
neoplasia, since these events promote a cellular turnover that provides an advantage for 
the carcinogenic process induced by HPV (34). Thus, since MMPs are important 
mediators of tissue remodeling and inflammation, it is to be expected that they act in the 
inflammatory process caused by C. trachomatis. We found that women infected by C. 
trachomatis had higher MMP-9 expression in relation to women negative for C. 
trachomatis. An earlier study on ocular trachoma induced by C. trachomatis showed an 
increase in inflammatory factors and MMPs, including MMP-9 (18). More recently, 
another study demonstrated an increase in production of MMP-9 and MMP-2 in 
organotypic cultures of the fallopian tube infected in vitro by C. trachomatis (17). 
However, as far as we know, this is the first study demonstrating the effect of C. 
trachomatis infection on MMP-9/RECK expression in the context of cervical 
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carcinogenesis.  
In addition to genital infections, behavior and physiological characteristics such as 
smoking, parity, oral contraceptives, alcohol and age at first sexual intercourse have 
been described as factors that influence acquisition of HPV and development of 
neoplastic lesion (35-38). In this context, we found a higher frequency of smoking 
patients in the study group when compared to the control group. In fact, a large 
longitudinal study have reported smoking as a risk factor for CIN3 and invasive cervical 
carcinoma (38). The induction of epigenetic changes could explain this finding, since it 
has been shown that smoking increases the risk of methylation of the tumor suppressor 
gene CDKN2A (p16), an epigenetic inactivation strongly associated with the 
pathogenesis of malignancies (39).  
In this study, the frequency of women having had first sexual intercourse at age 
below 15 years was significantly higher in the study group (44%) when compared to the 
control group (30%). Our data are in agreement with the literature, once sexual 
precocity is known to increase susceptibility to the first HPV infection, as well as 
exposure to the carcinogenic effects of HPV, which is associated with higher risk of 
CIN3 (35,36,40). On the other hand, CIN1 is associated to recent acquisition of HPV 
infection, regardless of the age of first sexual intercourse (36).  
In conclusion, our results show that higher expression of MMP-9 and lower 
expression of RECK is associated with high-grade cervical intraepithelial neoplasia. 
Moreover, we show that MMP-9/RECK imbalance is significantly associated with 
genital infection by C. trachomatis and infection by alpha-9 HPV, which includes 
HPV16. Genital infection by C. trachomatis is also associated with high-grade CIN and 
SCC, suggesting that infection by C. trachomatis could act as a cofactor in HPV-
on August 19, 2015. © 2015 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on August 10, 2015; DOI: 10.1158/1055-9965.EPI-15-0420 
20 
 
mediated cervical carcinogenesis and that the MMP-9/RECK imbalance during cervical 
inflammation might play an important role in this context. 
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Tables 
Table 1: Profile of social and demographic characteristics in the study groups  
 
 
on August 19, 2015. © 2015 American Association for Cancer Research. cebp.aacrjournals.org Downloaded from 
Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 
Author Manuscript Published OnlineFirst on August 10, 2015; DOI: 10.1158/1055-9965.EPI-15-0420 
27 
 
 
 
Variable 
Study group   
CIN2/CIN3/SCC No neoplasia/CIN1 *p-value 
n (136) (%) n (196) (% ) 
Age (years) 0.28 
≤ 29 44 (33) 48 (25)  
30-39 48 (35) 79 (40)  
≥ 40  44 (32) 69 (35)  
Age at first sexual 
intercourse      
≤15 60 (44) 59 (30) 0.008 
>15 76 (56) 137 (70)  
Ethnicity     0.78 
Black 40 (29) 55 (28) 
White 96 (71) 141 (72) 
Parity     0.003 
Multiparous 110 (81) 180 (92)  
Nulliparous 26 (19) 16 (08)  
Smoking     0.001 
Smoker or former smoker 50 (37) 41 (21) 
Non-smoker 86 (63) 155 (79) 
  *Chi-square test. 
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Table 2: HPV infection in relation to MMP-9 and RECK expression by immunocytochemistry 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 HPV-
negative 
(ref) 
HPV HPV 16 Alpha-9 HPV Alpha-7 HPV 
 n (%) n (%) *OR 
(CI 95%) 
n (%) *OR 
(CI 95%) 
n (%) *OR 
(CI 95%) 
n (%) *OR 
(CI 95%) 
MMP-9          
Moderate 
/accentuated 
65(44) 109 (67) 2.5 
(1.6-4.0) 
55 (72) 3.3 
(1.8-6.0) 
93(70) 3.0 
(1.8-4.9) 
12 (52) 1.5 
(0.6-3.7) 
Negative/mild 82(56) 54 (33)  21(27)  39 (30)  11(48)  
          
RECK          
Moderate 
/accentuated 
63 (41) 41(25) 0.48 
 (0.3-0.7)
20 (26) 0.5 
(0.3-0.9) 
33 (25) 0.48 
(0.3-0.8) 
6 (26) 0.5 
(0.2-1.3) 
Negative/mild 90 (59) 121 (75)  57(74)  98 (75)  17(74)  
          
*Odds ratio by multiple logistic regression. Adjustment variables: age, age at first sexual intercourse, ethnicity, education, parity, smoking and genital infections.
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Table 3: Genital infections in relation to MMP-9 and RECK expression by immunocytochemistry, HPV infection and cervical lesions 
 *General genital infection Bacterial vaginosis Chlamydia trachomatis 
 Positive Negative **OR 
(CI 95%) 
Positive Negative **OR 
(CI 95%) 
Positive Negative **OR 
(CI 95%) 
 n (%) n (%)  n (%) n (%)  n (%) n (%)  
          
MMP-9    
Moderate 
/accentuated 
79 (63) 86 (53) 1.4 
 (0.8-2.4) 
43 (61) 141 (56) 1.3 
(0.7-2.2) 
25 (76) 130 (54) 2.6  
(1.1-6.6) 
Negative/mild 46 (34) 76 (47) 27 (39) 110 (43) 8 (24) 111 (46)
          
RECK          
Moderate 
/accentuated 
40 (31) 65 (40) 0.7 
 (0.4 -1.3) 
23 (32) 88 (34)  1.1 
 (0.6-2.0) 
7 (20) 98 (40) 0.3 
 (0.2-0.9)
Negative/mild 88 (69) 99 (60)  49 (68) 167 (66)  27 (80) 148 (60)  
          
HPV          
Positive 72 (57) 68 (43) 1.2  
(0.6-2.6) 
43 (59) 123 (50) 1.3  
(0.8-2.3) 
17 (55) 111 (46) 1.4 
(0.6-3.0) 
Negative 54 (43) 91 (57)  30 (41) 124 (50)  14 (45) 130 (54)  
          
HPV multiple 
infection 
         
Yes 26 (36) 21 (31) 1.2 
 (0.6-2.6) 
15 (35) 37 (30) 1.4 
 (0.6-3.0) 
9 (53) 34 (31) 2.7  
(0.8-9.0) 
No 46 (64) 46 (69)  28 (65) 85 (70)  8 (47) 76 (69)  
          
Study groups          
CIN2/CIN3/SCC 61 (47) 52 (31) 1.4  
(0.8-2.8) 
34 (47) 102 (39) 0.9 
 (0.5-1.8) 
19 (56) 82 (33) 3.7 
 (1.3-11.3) 
No neoplasia/ 
CIN 1 
69 (53) 115 (69)  39 (53) 157 (61)  15 (44) 168 (77)  
*General genital infections include Candida spp, bacterial vaginosis, Chlamydia trachomatis, Neisseria gonorreheae,  Trichomonas vaginalis, HSV-1, HSV2 and 
Treponema pallidum.  
**Odds ratio by multiple logistic regression. Adjustment variables: age, age at first sexual intercourse, ethnicity, parity and smoking.  
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Table 4: MMP-9 and RECK expression by immunocytochemistry in relation to cervical lesions 
 no 
neoplasia/ 
CIN1 
CIN2/ 
CIN3/ 
SCC 
 **no 
neoplasia 
CIN1 CIN2 CIN3 SCC 
 n (%) n(%) *OR  
(CI 95%) 
n(%) n(%) *OR 
 (CI 95%) 
n(%) *OR 
 (CI 95%) 
n (%) *OR 
(CI 95%) 
n(%) *OR 
(CI 95%)
MMP-9             
Moderate 
/accentuated 
82 (44) 102 (76) 4.2 
(2.2-7.8) 
74(45) 8 (38) 1.6 
(0.5-5.6) 
23 (77) 3.1 
(1.0-9.9) 
61(77) 5.4 
(2.4-12.4) 
18 (72) 2.1 
(0.5-8.7) 
 
Negative/mild 
 
05 (56) 
 
32 (24) 
  
92(55) 
 
13 (62) 
  
7 (23) 
  
18 (23) 
  
7 (28) 
 
             
RECK             
Moderate 
/accentuated 
85 (44) 26 (20) 0.4 
(0.2-0.7) 
77 (45) 8 (32) 0.7 
(0.05-2.4) 
3 (10) 0.2 
(0.05-0.84) 
17 (22) 0.4 
(0.2-0.9) 
6 (24) 0.4 
(0.1-2.0) 
 
Negative/mild 
 
110 (56) 
 
106 (80) 
  
93 (55) 
 
17 (68) 
  
26(90) 
  
61 (78) 
  
19(76) 
 
             
*Odds ratio by multiple logistic regression. Adjustment variables: age, age at  first sexual intercourse, ethnicity, education, parity, smoking habit and genital infections.
**Negative cases for cervical lesion were used as reference for individual analysis of CIN1, CIN2, CIN3 and SCC.
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Figure Legends:  
Figure 1: Electrophoretic analysis of the amplified fragments by multiplex polymerase chain reaction in 
8% polyacrylamide gel stained with ethidium bromide. Lane C1: positive control of T.  vaginalis and 
HSV-1 (170 and 123 base pairs (bp)); lane C2: positive control of HSV-2, M. genitalium and T.  vaginalis 
(249, 193 and 170 bp); lane C3: positive control of C. trachomatis and T. pallidum (361 and 291 bp); lane 
C4: positive control of T. pallidum and HSV-2 (291 and 249 bp); lane C5: positive control of N. 
gonorrhoeae (162 bp); lane A1: positive sample for C. trachomatis (361 bp); lane A2: positive sample for  
T. vaginalis (170 bp); lane A3: positive sample for HSV-2 (249 bp); lane A4: positive sample for T. 
pallidum (291 bp); lane A5: positive sample for N. gonorrhoeae and HSV-1 (162 and 123 bp); lane A6: 
positive sample for N. gonorrhoeae (162 bp); lane A7: positive sample for T. vaginalis (170 bp); lane A8: 
positive sample for M. genitalium and T. vaginalis (193 and 170 bp); lane C-: negative control; M: 
molecular weight marker (25 bp Invitrogen).  
 
Figure 2: mRNA and protein expression of MMP-9 and RECK in cervical samples. Figures 2A, 2B, 2D 
and 2E represent immunocytochemical analysis:  A) mild expression of MMP -9 in normal Pap-smear; B) 
accentuated expression of MMP-9 in CIN3; D) accentuated expression of RECK in normal Pap-smear; E) 
mild expression of RECK in CIN3 (Nikon ACT-1 1.200C DXM with 400x optical zoom). Figures 2C and 
2F: graphical representation of gene expression of MMP-9 (C) and RECK (F) in the study groups. *p=0.2; 
** p= 0.03 
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